Investor Alert

Alexion Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 5, 2021, 5:29 p.m.





0.00 0.00%


Volume 89,322

Quotes are delayed by 20 min


Previous close

$ 148.46

$ 150.10


+1.64 +1.10%

Day low

Day high




52 week low

52 week high




Annual Financials for Alexion Pharmaceuticals Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries 399M443.3M77.6M2.4B603.4M
Depreciation, Depletion & Amortization 386M487.5M397.3M376.8M329.4M
Depreciation and Depletion 64M95.8M77.9M61.8M71.8M
Amortization of Intangible Assets 322M391.7M319.4M315M257.6M
Deferred Taxes & Investment Tax Credit 104M(45.9M)32.9M(455.4M)(283.4M)
Deferred Taxes 104M(45.9M)32.9M(455.4M)(283.4M)
Investment Tax Credit -----
Other Funds 333M401.2M352.4M35.6M2.39B
Funds from Operations 1.22B1.29B860.2M2.36B3.04B
Extraordinaries -----
Changes in Working Capital (136M)(170.5M)(434.2M)(276.4M)(33.8M)
Receivables (122M)(55.2M)(208.8M)(319.2M)(139.4M)
Accounts Payable ---230.7M122.5M
Other Assets/Liabilities 70M(27.1M)(210.7M)(31M)(111.9M)
Net Operating Cash Flow 1.09B1.12B426M2.08B3B

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (333M)(357.3M)(213M)(170.7M)(106.7M)
Capital Expenditures (Fixed Assets) (333M)(357.3M)(213M)(154.7M)(106.7M)
Capital Expenditures (Other Assets) ---(16M)-
Net Assets from Acquisitions ----(2.11B)
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments 47M(561.1M)680.7M180.5M119.1M
Purchase of Investments (675M)(1.66B)(805.1M)(171.1M)(77.2M)
Sale/Maturity of Investments 722M1.1B1.49B351.6M196.3M
Other Uses (1M)--(100,000)-
Other Sources -100,0002.8M--
Net Investing Cash Flow (287M)(918.3M)470.5M9.7M(2.1B)

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock (393M)(377.7M)(37.7M)(386.1M)(452.1M)
Repurchase of Common & Preferred Stk. (430M)(463.6M)(85M)(416M)(510.8M)
Sale of Common & Preferred Stock 37M85.9M47.3M29.9M58.7M
Proceeds from Stock Options -----
Other Proceeds from Sale of Stock 37M85.9M47.3M29.9M58.7M
Issuance/Reduction of Debt, Net (375M)(175M)(43.8M)(348M)(130.6M)
Change in Current Debt --250M(250M)-
Change in Long-Term Debt (375M)(175M)(293.8M)(98M)(130.6M)
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt (375M)(175M)(293.8M)(98M)(130.6M)
Other Funds (68M)(43.9M)(20.9M)(5M)(29.2M)
Other Uses (68M)(43.9M)(20.9M)(5M)(29.2M)
Other Sources -----
Net Financing Cash Flow (836M)(596.6M)(102.4M)(739.1M)(611.9M)
Exchange Rate Effect (7M)17.7M(11.2M)800,00019.5M
Miscellaneous Funds -----
Net Change in Cash (44M)(381.6M)782.9M1.36B311M
Free Cash Flow 753M758.3M213M1.93B2.9B
Link to MarketWatch's Slice.